Drug Database
L01FD01 trastuzumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Herceptin 150 mg powder for concentrate for solution for infusion (Northern Ireland)
- POM Herceptin 150mg Powder for concentrate for solution for infusion
- POM Herceptin 600 mg Solution for Injection in Vial
- POM Herzuma 150 mg and 420 mg powder for concentrate for solution for infusion ▼
- POM Herzuma 150 mg and 420 mg powder for concentrate for solution for infusion (NI) ▼
- POM Herzuma 420 mg powder for concentrate for solution for infusion ▼
- POM KANJINTI ▼
- POM Ontruzant 150 mg powder for concentrate for solution for infusion ▼
- POM Ontruzant 150 mg powder for concentrate for solution for infusion (Northern Ireland) ▼
- POM Trazimera 150mg powder for concentrate for solution for infusion ▼
- POM Trazimera 420mg powder for concentrate for solution for infusion ▼
- POM Zercepac 150mg powder for concentrate for solution for infusion. ▼
- POM Zercepac 60 mg powder for concentrate for solution for infusion ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).